Amgen at PMWC 2027
Jan 27–29, 2027 Santa Clara, CA ~3k attendees Website
Amgen takes part in 3 sessions at PMWC 2027 in Santa Clara. Its program runs from targeted protein degradation and molecular glues to residual disease as a drug approval endpoint. It also joins a session on how payers decide what precision medicine gets covered.
| Organization | PMWC 2027 Attendance |
|---|---|
Amgen Thousand Oaks, CA | |
Biotechnology company with marketed medicines in oncology, inflammation, cardiovascular and bone disease, and a large research and development pipeline. | PMWC Pioneer Award honoree Panel Thu Jan 28 11:00am Panel Thu Jan 28 3:30pm Panel Fri Jan 29 9:30am |
Find decision makers at Amgen
Tell us what you sell and we’ll find the people at Amgen most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by PMWC or its organizers. Submit a correction